Discover our latest insights. 

Each June, over 40,000 oncology professionals, including physicians, researchers, patient advocates, and pharmaceutical representatives attend the American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. This meeting is considered the premiere forum for the presentation of the most recent scientific progress made in the fight against cancer.

This year, our Chief Scientist and Senior Vice President of Research, Eva Gordon, PhD and members of our Personal Care Teams of research scientists and advanced practice clinicians attended dozens of presentations to learn the latest clinical data and emerging technologies. They also connected with oncologists, patient advocates, and technology leaders in the cancer community. Here’s some of the most exciting developments at ASCO 2023.

While our skin needs protection from the sun throughout the year, the increased time spent in the sun during the summer can raise the risk of skin damage and skin cancer.

Here is PHM’s recommended checklist on the best ways to protect yourself from the sun’s damaging UV rays and reduce your risk of developing skin cancer.

Hot flashes are the most common symptom of menopause, occurring in 75% of all women and often persisting for years. For some women, hot flashes are mild, infrequent, and do not require treatment. Others have more intense and frequent hot flashes that negatively affect their quality of life, including sleep interruption, mood changes, difficulty concentrating, and interference with daily activities. Read now for a brief review the existing treatments and a newly approved, non-hormonal treatment option.

For a very long time, the only option for breast cancer treatment was a radical mastectomy. Treatment slowly began to evolve in the 1960s with hormone therapy, radiation, and chemotherapy being adopted into clinical practice. But today, treatment options are evolving much more rapidly.